MUC5AC protein may predict pancreatic cancer prognosis: Study
1 Articles
1 Articles
MUC5AC protein may predict pancreatic cancer prognosis: Study
Blood levels of the MUC5AC protein could help predict outcomes in people who have surgery for pancreatic ductal adenocarcinoma (PDA), the most common type of pancreatic cancer, a study shows. In people whose treatment plan involved chemotherapy before surgery (neoadjuvant treatment), higher MUC5AC levels were generally linked to less favorable disease characteristics and a worse prognosis. For those who had surgery followed by chemotherapy (adju…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage